FEMSelect, developer of EnPlace, a minimally invasive, meshless approach to pelvic floor ligament fixation, has raised $9M Series B funding led by New Age Ventures and co-led by TriVentures. Other participants in the round include Robin Hood Ventures, Mid Atlantic Bio Angels (MABA), MEDA Angels, Keiretsu Forum Mid-Atlantic, RAD BioMed, Keiretsu Capital and Transpacific Venture Partners. FEMSelect’s EnPlace system’s approach is cleared by the FDA…
Stress Urinary Incontinence (SUI) is the most common type of urinary incontinence. According to estimations around 1 in 3 women will experience bladder leakage at some point in their life. SUI happens when the sphincter muscle that controls the urethra, the pelvic floor tissues and muscles that are used to keep the urethra closed, weakens. Urolon developed by Netherlands-based AQLANE Medical, is…
Renovia, a developer of non-surgical, treatments for female pelvic floor disorders and an advocate for women’s health, announced today that the U.S. Food and Drug Administration (FDA) has cleared its leva Pelvic Health System for the first-line treatment of chronic fecal incontinence (FI) in women. The decision follows the grant of Breakthrough Device Designation by FDA in October 2021. leva had previously been cleared by FDA to…
A new survey commissioned by women’s health company Hologic revealed a lack of awareness among U.S. women about uterine health, including uterine fibroid symptoms and treatment options. The company is also launching Hey, U!, a educational campaign focused on uterine health. Uterine fibroids are very common, affecting up to 80% of women by the age of 50. Even so, Hologic’s survey found that 48%…
Renovia, a women-led company that develops digital therapeutics for female pelvic floor disorders, announced today that researchers presented new data supporting the value of the leva® Pelvic Health System in treating female urinary incontinence (UI). Three accepted abstracts showed that leva delivers durable UI symptom improvement for 12 months following eight weeks of therapy, generates valuable real-world data that both supports leva’s effectiveness and provides an opportunity to…
Hinge Health, the digital musculoskeletal clinic is doubling down on women’s health and launching a new program dedicated to women’s pelvic health. announces the launch of a Women’s Pelvic Health program. One in four women has a pelvic floor disorder. Yet most women don’t receive treatment due to a lack of awareness, stigma, and inadequateaccess to pelvic floor physical therapists resulting in an…
Around 25% of adult women and more than 50% of women aged 80+ are affected by pelvic floor disorder like pelvic organ prolapse (POP). Despite this high prevalence, many of them are suffering in silence due to stigmatization or lack of access to effective treatment. Cosm, a Canadian startup, is now stepping up to bring change to this underserved space with Gynethotics,…
SWORD Health, known for tis digital musculoskeletal care offering, is entering the women’s health market with the launch of Bloom, a at-home physical health therapy solution for women. In the US alone, one in every four women suffer from pelvic health disorders. These conditions include sexual health, bowel or bladder and pelvic pain disorders, which can be present through all stages of…
